Amy Schulman Net Worth & Insider Trades

Amy Schulman - Director, Cyclerion Therapeutics, Inc

As of June 18, 2020

What is Amy Schulman's Net Worth?

The current estimated net worth of Cyclerion Therapeutics, Inc's Director, Amy Schulman, is estimated to be about $17.02M . Amy Schulman owns about 29,143 units of Cyclerion Therapeutics, Inc common stock. In the last year at Cyclerion Therapeutics, Inc, Amy Schulman has sold an estimated value of $0 worth.

What is Amy Schulman's Past Insider Trading?

Amy Schulman's largest purchase order was 626,117 units , worth over $10.02M on April 10, 2019. In total, Amy Schulman has made about 4 transactions over a year of their time at Cyclerion Therapeutics, Inc. Amy Schulman usually trades in June and April, with the busiest year in 2019.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AMY SCHULMAN

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Amy Schulman's' Mailing Address?

  • Mailing address is Pfizer Inc. Attn: Corporate Secretary 235 East 42nd Street New York NY 10017 NY

What are Cyclerion Therapeutics, Inc's Past Insider Trades?

Cyclerion Therapeutics, Inc's most recent insider trade came on August 11, 2023 by Terrance McGuire who sold 8 units worth $27.16 . In the last 4 years, insiders at Cyclerion Therapeutics, Inc have sold an estimated value of $240.02K and bought an estimated value of $34.97M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Peter Hecht, Chief Executive Officer,  Terrance McGuire, Director,  and Andreas Busch, Chief Scientific Officer .

Cyclerion Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...